Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
Saturday, December 19, 2020 2:16:43 PM
BTS Research coming into the picture is one of the single best developments so far for reason they're your classic Contract Research Organization (CRO) I spoke of in a previous post about Protheragen. Apparently, BTS is picking up where Protheragen left off?
Fundamentally, BTS is the catalysts for systematically moving toward clinical trials with FDA approval for commercialization. However, with this move, I discern something happened with the arrangements BioClonetics had with Protheragen for reason BTS does the exact same thing as Protheragen.
http://btsresearch.com/
Next up multi-Source funding will likely come into place soon as well as the appearance of a Bigpharma partner both of which combined will definitely send the PPS Northward!
IMO...Spring (March-April) will be a major "milestone" transitional period for this company with everything coming into place as it should.
It will be absolutely "transformational" and with this the PPS should be between $1-$2 keeping in mind that the STOP SIGN would be long gone by then.
Be well and prosper...
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM